Oramed Pharmaceuticals Inc. (NASDAQ: ORMP)
$2.56
+0.0300 ( +1.19% ) 101.9K
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Market Data
Open
$2.56
Previous close
$2.53
Volume
101.9K
Market cap
$104.01M
Day range
$2.50 - $2.60
52 week range
$1.67 - $3.67
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 1 | Jan 02, 2024 |
8-k | 8K-related | 12 | Dec 21, 2023 |
8-k | 8K-related | 12 | Dec 18, 2023 |
10-q | Quarterly Reports | 53 | Nov 09, 2023 |
8-k | 8K-related | 25 | Sep 26, 2023 |
8-k | 8K-related | 14 | Sep 13, 2023 |
8-k | 8K-related | 13 | Aug 22, 2023 |
10-q | Quarterly Reports | 53 | Aug 10, 2023 |
8-k | 8K-related | 14 | Aug 09, 2023 |
8-k | 8K-related | 13 | Aug 07, 2023 |